43851 Deucravacitinib Long-term Efficacy With Continuous Tre…
Emerging
0
Citations0
Refs2023
Year
Search Works
Work Details
- DOI 10.1016/j.jaad.2023.07.144
- OpenAlex ID W4387014971
- Type Article
- Language EN
- Published 01 Sep 2023
- Volume 89 (3)
- Pages AB35
- Source Journal of the American Academy of Derma…
- Publisher Elsevier BV
- Countries 3
- Institutions 8
- Added 26 Sep 2023
- Updated 16 Oct 2026
External Links
MENU
0
43851 Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and POETYK PSO-LTE Trials
Article 2023 EN Bronze
0
Citations
0
References
11
Authors
0.00
FWCI
Topics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
11 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Mark Lebwohl | Icahn School of Medicine at Mo… (US) | |
| 2 | Richard Bruce Warren | Salford Royal NHS Foundation T… (GB) University of Manchester (GB) +1 | |
| 3 | Leon Kircik | Icahn School of Medicine at Mo… (US) | |
| 4 | Elizabeth Colston | Bristol-Myers Squibb (United S… (US) | — |
| 5 | Lauren Hippeli | Bristol-Myers Squibb (United S… (US) | — |
| 6 | Andrew Napoli | Bristol-Myers Squibb (United S… (US) | — |
| 7 | Renata M. Kisa | Bristol-Myers Squibb (United S… (US) | — |
| 8 | Subhashis Banerjee | Bristol-Myers Squibb (United S… (US) | |
| 9 | Alan Menter | Baylor University Medical Cent… (US) | |
| 10 | Diamant Thaçi | University of Lübeck (DE) | |
| 11 | Andrew Blauvelt | Oregon Medical Research Center (US) |
Related Works
10Data: OpenAlex